Novartis Bone Drug Appeal Won't Get High Court Review

Law360, New York (November 5, 2012, 2:46 PM EST) -- The U.S. Supreme Court on Monday declined to hear an appeal from the widow of a cancer patient who claims that the Sixth Circuit improperly excluded expert causation testimony from the victim's doctor in a bone drug liability suit against Novartis Pharmaceuticals Corp.

The high court's decision denying the petition for writ of certiorari solidifies the appeals court's decision in June, which found that experts testifying on behalf of the victim were not qualified to establish a link between osteonecrosis of the jaw and the drugs...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.